CDKN2B expression and subcutaneous adipose tissue expandability: Possible influence of the 9p21 atherosclerosis locus

Biochemical and Biophysical Research Communications

Volumn 446, Issue 4, 2014, Pages 1126-1131

  Svensson, Per Arne ^a   Wahlstrand, Björn ^a   Olsson, Maja ^a   Froguel, Philippe ^b   Falchi, Mario ^b   Bergman, Richard N ^c   McTernan, Philip G ^d   Hedner, Thomas ^a   Carlsson, Lena M S ^a   Jacobson, Peter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Adipose tissue; CDKN2B; Chromosome 9p21

Indexed keywords

ADIPOSE TISSUE; CDKN2B; CHROMOSOME 9P21;

ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P15; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; GENETIC LOCI; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SUBCUTANEOUS FAT;

EID: 84899476374     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.075     Document Type: Article

References (41)

1. A.D. Lopez, C.D. Mathers, M. Ezzati, and D.T. Jamison Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet 367 2006 1747 1757
2. T. Zeller, S. Blankenberg, and P. Diemert Genomewide association studies in cardiovascular disease-an update 2011 Clin. Chem. 58 2012 92 103
3. H.M. Broadbent, J.F. Peden, S. Lorkowski, and A. Goel et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p Hum. Mol. Genet. 17 2008 806 814
4. A. Helgadottir, G. Thorleifsson, A. Manolescu, and S. Gretarsdottir et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493
5. R. McPherson, A. Pertsemlidis, N. Kavaslar, and A. Stewart et al. A common allele on chromosome 9 associated with coronary heart disease Science 316 2007 1488 1491
6. G.E. Palomaki, S. Melillo, and L.A. Bradley Association between 9p21 genomic markers and heart disease: a meta-analysis JAMA 303 2010 648 656
7. N.J. Samani, J. Erdmann, A.S. Hall, and C. Hengstenberg et al. Genomewide association analysis of coronary artery disease N. Engl. J. Med. 357 2007 443 453
8. N.P. Paynter, D.I. Chasman, J.E. Buring, and D. Shiffman et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3 Ann. Intern. Med. 150 2009 65 72
9. H. Schunkert, A. Gotz, P. Braund, and R. McGinnis et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease Circulation 117 2008 1675 1684
10. B. Wahlstrand, M. Orho-Melander, L. Delling, and S. Kjeldsen et al the myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension J. Hypertens. 27 2009 769 773
11. R. Do, C. Xie, X. Zhang, and S. Mannisto et al the effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study PLoS Med. 8 2011 e1001106
12. O. Jarinova, A.F. Stewart, R. Roberts, and G. Wells et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus Arterioscler., Thromb., Vasc. Biol. 29 2009 1671 1677
13. L. Folkersen, T. Kyriakou, A. Goel, and J. Peden et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants PloS One 4 2009 e7677
14. Y. Liu, H.K. Sanoff, H. Cho, and C.E. Burd et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis PloS One 4 2009 e5027
15. L.M. Holdt, F. Beutner, M. Scholz, and S. Gielen et al. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21 Arterioscler., Thromb., Vasc. Biol. 30 2010 620 627
16. M.S. Cunnington, M. Santibanez Koref, B.M. Mayosi, and J. Burn et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression PLoS Genet. 6 2010 e1000899
17. L.M. Holdt, K. Sass, G. Gabel, and H. Bergert et al. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque Atherosclerosis 214 2011 264 270
18. M.S. Cunnington, and B. Keavney Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus Curr. Atheroscler. Rep. 13 2011 193 201
19. A. Congrains, K. Kamide, M. Ohishi, and H. Rakugi ANRIL: molecular mechanisms and implications in human health Int. J. Mol. Sci. 14 2013 1278 1292
20. A. Motterle, X. Pu, H. Wood, and Q. Xiao et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells Hum. Mol. Genet. 21 2012 4021 4029
21. O. Harismendy, D. Notani, X. Song, and N.G. Rahim et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response Nature 470 2011 264 268
22. Y. Kojima, K. Downing, R. Kundu, and C. Miller et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis J. Clin. Invest. 124 2014 1083 1097
23. L.M.S. Carlsson, P. Jacobson, A. Walley, and P. Froguel et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease Biochem. Biophys. Res. Commun. 382 2009 309 314
24. L.A. Anderson, P.G. McTernan, A.H. Barnett, and S. Kumar The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site J. Clin. Endocrinol. Metab. 86 2001 5045 5051
25. H. Lantz, M. Peltonen, L. Agren, and J.S. Torgerson Intermittent versus on-demand use of a very low calorie diet: a randomized 2-year clinical trial J. Intern. Med. 253 2003 463 471
26. S. Ahlin, K. Sjoholm, P. Jacobson, and J. Andersson-Assarsson et al. Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity Obesity (Silver Spring) 21 2013 E571 576
27. H. Kvist, L. Sjostrom, and U. Tylen Adipose tissue volume determinations in women by computed tomography: technical considerations Int. J. Obes. 10 1986 53 67
28. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
29. J.P. Despres, and I. Lemieux Abdominal obesity and metabolic syndrome Nature 444 2006 881 887
30. P. Krimpenfort, A. Ijpenberg, J.Y. Song, and M. van der Valk et al. P15Ink4b is a critical tumour suppressor in the absence of p16Ink4a Nature 448 2007 943 946
31. E.D. Rosen, P. Sarraf, A.E. Troy, and G. Bradwin et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol. Cell 4 1999 611 617
32. C. Wang, N. Pattabiraman, J.N. Zhou, and M. Fu et al. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation Mol. Cell Biol. 23 2003 6159 6173
33. D. Zhao, X. Zhi, Z. Zhou, and C. Chen TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis Carcinogenesis 33 2012 59 67
34. K. Omagari, R. Takamura, S. Matsutake, and M. Ichimura et al. Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver J. Clin. Biochem. Nutr. 49 2011 200 206
35. S.D. Horswell, L.G. Fryer, C.E. Hutchison, and D. Zindrou et al. CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients J. Lipid. Res. 54 2013 3491 3505
36. L. Heilbronn, S.R. Smith, and E. Ravussin Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus Int. J. Obes. Relat. Metab. Disord. 28 Suppl. 4 2004 S12 S21
37. S.E. McQuaid, L. Hodson, M.J. Neville, and A.L. Dennis et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60 2011 47 55
38. A. Visel, Y. Zhu, D. May, and V. Afzal et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice Nature 464 2010 409 412
39. N. Mero, R. Malmstrom, G. Steiner, and M.R. Taskinen et al. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease Atherosclerosis 150 2000 167 177
40. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
41. M.E. Tushuizen, M. Diamant, and R.J. Heine Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes Postgrad. Med. J. 81 2005 1 6